To understand the impact of a COVID-19 diagnosis on TRAIL/IP-10 levels in maternal and cord blood, we also analyzed Group A, which consisted of participants who had received three doses of the COVID-19 vaccine but had not been diagnosed with COVID-19. This evidence concerns the gene CXCL10 and COVID-19.